Publication: Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project.
| dc.contributor.author | Camelo-Castillo, Amy | |
| dc.contributor.author | Rivera Caravaca, José Miguel | |
| dc.contributor.author | Marin, Francisco | |
| dc.contributor.author | Vicente, Vicente | |
| dc.contributor.author | Lip, Gregory Y | |
| dc.contributor.author | Roldán, Vanessa | |
| dc.contributor.department | Medicina | |
| dc.date.accessioned | 2024-02-08T09:08:58Z | |
| dc.date.available | 2024-02-08T09:08:58Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Background: The ABC (age, biomarkers, and clinical history)-stroke and ABC-bleeding are biomarker-based scores proposed to predict stroke and bleeding, but non-specificity of biomarkers is common, predicting different clinical events at the same time. We assessed the predictive performance of the ABC-stroke and ABC-bleeding scores, for outcomes beyond ischemic stroke and major bleeding, in a cohort of atrial fibrillation (AF) patients. Methods: We included AF patients stable on vitamin K antagonists for 6 months. The ABC-stroke and ABC-bleeding were calculated and the predictive values for myocardial infarction (MI), acute heart failure (HF), a composite of cardiovascular events, and all-cause deaths were compared. Results: We included 1,044 patients (49.2% male; median age 76 [71-81] years). During 6.5 (4.3-7.9) years, there were 58 (5.6%) MIs, 98 (9.4%) acute HFs, 167 (16%) cardiovascular events, and 418 (40%) all-cause deaths. There were no differences in mean ABC-stroke and ABC-bleeding scores in patients with/without MI (p = 0.367 and p = 0.286, respectively); both scores were higher in patients with acute HF, cardiovascular events, or death (all p < 0.05). Predictive performances for the ABC-stroke and ABC-bleeding scores were similar, ranging from "poor" for MI (c-indexes ∼0.54), "moderate" for acute HF and cardiovascular events (c-indexes ∼0.60 and ∼0.64, respectively), and "good" for all-cause mortality (c-indexes > 0.70). Clinical usefulness whether assessed by ABC-stroke or ABC-bleeding was similar for various primary endpoints. Conclusion: In AF patients, the ABC-stroke and ABC-bleeding scores demonstrated similar predictive ability for outcomes beyond stroke and bleeding, including MI, acute HF, a composite of cardiovascular events, and all-cause deaths. This is consistent with nonspecificity of biomarkers that predict "sick" patients or poor prognosis overall. | es |
| dc.format | application/pdf | es |
| dc.format.extent | 8 | es |
| dc.identifier.citation | Thrombosis and Haemostasis | |
| dc.identifier.doi | https://doi.org/10.1055/s-0040-1712914 | |
| dc.identifier.issn | 0340-6245 | |
| dc.identifier.uri | http://hdl.handle.net/10201/138957 | |
| dc.language | eng | es |
| dc.relation | Instituto de Salud Carlos III (PI17/01375 cofinanciado con fondos FEDER (European Regional Development Fund) y el grupo CB16/11/00385 de CIBERCV. | es |
| dc.rights | info:eu-repo/semantics/embargoedAccess | es |
| dc.subject | Fibrilacion auricular | es |
| dc.subject | Biomarcador | es |
| dc.subject | Ictus | es |
| dc.subject | Hemorragia | es |
| dc.title | Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project. | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
Collections
Sin licencia Creative Commons.